Revolution Medicines, Inc. — Director's Dealing 2021

Jan 9, 2021

SEC Form 4/A — Form 4/A

Issuer: Revolution Medicines, Inc. (RVMD)
CIK: 0001628171
Period of Report: 2020-12-30

Reporting Person: Weber Barbara (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-30	Stock Option (Right to Buy)	$1.12	J	0	Disposed	2028-04-19	N/A (0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1808	Direct

Footnotes

F1: On January 4, 2021, the reporting person filed a Form 4 reporting the exercise and sale of 5,336 shares of common stock. This Form 4 was mistakenly filed due to broker error and the exercise and sale did not in fact occur.

F2: Includes 1,808 Restricted Stock Units.

F3: This option is early exercisable. Twenty-five percent of the total shares subject to the option vested on the first anniversary measured from April 20, 2018 (the "Vesting Commencement Date") and one sixteenth (1/16th) of the shares subject to the option will vest quarterly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each such vesting date.